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Abstract
Introduction: Dendritic cells (DCs) are required for initiation of the immune response and may therefore be used for the pro-
duction of cancer vaccines. As mature DCs (mDCs) are the most potent antigen-presenting cells, there is increasing interest
in generating them ex vivo. The present study was designed to obtain mDCs from CD34+ hematopoietic progenitors by cul-
turing them in different media. 
Materials and Methods: Cord blood CD34+ hematopoietic progenitors were expanded for 7 days in FST medium containing
fms-related tyrosine kinase 3 ligand (Flt3-L), stem cell factor (SCF), and thrombopoietin (TPO). Then the cells were divid-
ed into three parts and cultured for 21 days in different media: FST medium or FST enriched in interleukin (IL)-3 (FST3
medium) or supplemented with IL-7 and IL-13 (FST713 medium). At the end of culture part of the cells was harvested,
counted, and analyzed while the other part was matured with proinflammatory cytokines for 2 days. The cells’ phenotypes,
ability to induce proliferation of allogeneic lymphocytes in the mixed lymphocyte reaction (allo-MLR), chemotaxis, phago-
cytosis, and O2
– production were determined. 
Results: The average fold increase of DCs at the end of culture in FST medium was 127, in FST3 1043, and in FST713 71. In
comparison with the other media, FST713 medium supported the generation of mDCs that were characterized by higher
expression of CD83, costimulatory molecules, and HLA-DR, enhanced ability to induce allo-MLR and migration to
macrophage inflammatory protein (MIP) 3β, poor phagocytosis, and O2
– production. 
Conclusions: This study indicates that FST713 medium allows the generation of limited numbers of more mature DCs, while
FST3 medium leads to the production of immature DCs in high numbers. 
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INTRODUCTION
Dendritic cells (DCs) are the most potent antigen-
presenting cells and are required for the initiation of an
immune response by stimulating naïve, memory, and
effector T cells. They possess a wide spectrum of activi-
ty, ranging from induction of tolerance and prevention
of autoimmunity to induction of antitumor response and
protection against infectious agents (Banchereau and
Steinman 1998; Liu 2001). It is still an open question
whether these activities are associated with separate
subsets of DCs, their stage of maturation, or both (Liu
2001). There is growing interest in the development of
methods which allow the generation of large numbers of
DCs as they may be clinically useful in the production of
cancer vaccines (Banchereau et al. 2001). Monocytes
are the most commonly used source of DC precursors
(Sallusto and Lanzavecchia 1994). Another possibility is
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to use CD34+ hematopoietic precursors from umbilical
cord or peripheral blood which, in contrast to mono-
cytes, proliferate in in vitro culture. Moreover, using var-
ious combinations of growth factors and cytokines it is
possible to obtain DCs in different stages of maturation
(immature: iDCs, mature: mDCs) and/or their different
subsets (DC1, DC2) (Zou and Tam 2002). 
A large variety of cytokines and conditions have
been used for generating DCs which showed hetero-
geneity in phenotype and biological function. Medium
containing fms-related tyrosine kinase 3 ligand (Flt3-L),
stem cell factor (SCF), thrombopoietin (TPO), and
interleukin (IL)-3 (FST3 medium) is one of commonly
used for the expansion of DCs from CD34+ hematopoi-
etic progenitor cells (Arrighi et al. 2003; Bontkes et al.
2002). When monocytes are used as a source of DCs,
medium enriched with granulocyte-macrophage colony-
-stimulating factor (GM-CSF) and IL-4 is the most pop-
ular (Li et al. 2000; Romani et al. 1996; Zou and Tam
2002). In some experiments, IL-4 was replaced with IL-7
and it was shown that these DCs were more effective in
enhancing anti-EBV T-cell cytotoxicity and prolifera-
tion of CD4 and CD8 T cells than DCs generated in
GM-CSF and IL-4 (Takahashi et al. 1997). The surface
markers exhibited by these cells were typical of those
expressed by GM-CSF- and IL-4-derived DCs except
that in contrast to the “classical” IL-4-derived DCs,
IL-7-derived DCs showed CD14 expression (Li et al.
2000). When used with GM-CSF, IL-13, which shares
many properties with IL-4 (Piemonti et al. 1995), pro-
motes the differentiation of DCs from adherent periph-
eral blood mononuclear cells (Ahn and Agrawal 2005).
Moreover, IL-13-generated DCs did not express CD14
molecules (Morse et al. 1999) and morphologically, phe-
notypically, and functionally were more mature than
GM-CSF- and IL-4-induced DCs (Sato et al. 1999).
These observations are in disagreement with other data
which showed that IL-13 DCs are less differentiated
than IL-4 DCs (Ahn and Agrawal 2005).
There are few studies concerning the effect of the
above cytokines on the generation of DCs from cord
blood CD34+ cells. Rosenzwajg et al. (Rosenzwajg et al.
1998) examined cord blood CD34+ cells cultured for the
entire period in SCF, Flt3-L, GM-CSF, and TNFα
medium with 10% FCS. After 5 days of culture, IL-4 or
IL-13 was added, which allowed the generation of
a large proportion of CD1a+ DCs. Similar results were
presented by Di Nicola et al. (Di Nicola et al. 1999) on
CD34+ cells from mobilized peripheral blood. Against
this background it was reasoned that the use of IL-7 and
IL-13 jointly may result in the generation of more
mature DCs without the requirement of their further
differentiation with proinflammatory cytokines.
In the present study the phenotype and some biolog-
ical activities of DCs originating from CD34+ hema-
topoietic progenitors cultured in FST medium (FST-
-DCs) or in FST3 (FST3-DCs) or FST713 (FST713-
DCs) media were determined. The CD34+ cells were
first expanded in FST medium for 7 days, then divided
and cultured in the three media for a further 21 days. We
demonstrate that in comparison with the other media,
FST713 medium supports the generation of mDCs char-
acterized by higher levels of CD83, costimulatory mole-
cules, and HLA-DR expression, an increased allostimu-
latory capacity and, following maturation, enhanced
migration to MIP3β and increased expression of CCR7.
MATERIALS AND METHODS
Isolation of CD34+ cells
Human umbilical cord blood samples were obtained
from normal full-term deliveries according to institu-
tional guidelines. Mononuclear cells were isolated by
standard Ficoll/Isopaque (Pharmacia, Uppsala, Swe-
den) density gradient centrifugation, incubated with bi-
specific anti-CD34 monoclonal antibody (mAb), anti-
-dextran tetrameric antibody complexes, and dextran-
coated magnetic nanoparticles. The magnetically
labeled cells were then separated in a magnetic field
according to the manufacturer’s protocol (EasySep;
StemCell Technologies, Vancouver, Canada). The puri-
ty of the isolated cells was in the range of 89–95% as
analyzed by flow cytometry (FACSCalibur, Becton
Dickinson Immunocytometry System, San Jose, CA,
USA) following staining with anti-CD34 mAb (Becton
Dickinson, San Diego, CA, USA). The isolated CD34+
cells were suspended in Iscove’s medium (Gibco,
Paisley, UK) supplemented with 10% fetal bovine
serum (Biochrom, Berlin, Germany), 2 mM L-gluta-
mine (Gibco), 10 mM hepes (Gibco), 2×10–5 M 2-mer-
captoethanol, and antibiotics (PNS; Gibco), further
referred to as complete medium.
Generation of dendritic cells
For expansion, the CD34+ cells were cultured in
complete medium enriched with 30 ng/ml recombinant
human (rh) Flt3-L (specific activity: 1×106 U/mg;
CytoLab, Rehovot, Israel), 30 ng/ml rhSCF (specific
activity: 5×105 U/mg; CytoLab), and 15 ng/ml rhTPO
(specific activity: 1×106 U/mg; CytoLab) (FST medium)
in ultra-low-attachment six-well plates (Corning Inc.,
New York, NY, USA) at 2–5×104/ml. On the fourth
day, half of the medium was replaced with fresh medi-
um. After one week the cells were harvested, counted,
and placed (at 5×104/ml) in the following media: FST or
FST further enriched in 30 ng/ml rhIL-3 (specific activ-
ity: 0.6–1×107 U/mg; R&D, Abington, UK) (FST3
medium) or 50 ng/ml rhIL-7 (specific activity: 2×106
U/mg; CytoLab) and 30 ng/ml rhIL-13 (specific activity:
1×106 U/mg; CytoLab) (FST713 medium). The cells
were incubated at 37°C in a 5% CO2 atmosphere for
a further 21 days, replacing the medium every fourth
day. On day 21 the cells were collected for analysis of
phenotype and biological activities. The remaining cells,
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a cocktail of proinflammatory cytokines containing
rhIL-1β( (Sigma, St. Louis, MO, USA) at 2 ng/ml, rhIL-6
(Sigma) at 10 ng/ml, tumor necrosis factor α (TNFα,
a gift from Prof. W. Stec, Polish Academy of Science,
Lodz, Poland; specific activity: 3×107 U/ml) at 5 ng/ml,
and prostaglandin E2 (PGE2; Sigma) at 1 µM for a fur-
ther 2 days and then harvested for analysis. 
Determination of immunophenotype
The following fluorescein (FITC)- or phycoerythrin
(PE)-conjugated mouse anti-human mAbs were used:
anti-CD1a (clone HI149), -CD40 (clone 5C3), -CD83
(clone HB15e), -CD80 (clone L307.4), -CD86 (clone
2331), -CD33 (clone HIM3-4), -CD14 (clone MoP9),
-HLA-DR (clone L243), -CD11c (clone B-ly6), -man-
nose receptor (MR, clone 19.2), -CD123 (clone 9F5),
-CD16 (clone 3G8), and -CD45RA (clone HI100), all
from BD Pharmingen, and anti-CD36 (clone FA6.152)
from Immunotech (Marseille, France). For chemokine
receptor analysis, anti-CCR5 (clone2D7/CCR5) mAb
from BD Pharmingen and anti-CCR1 (clone 53504) and
-CCR7 (clone 150503) from R&D were used. Isotype
controls included the appropriate FITC- or PE-labeled
mouse IgG1, IgG2a, or IgG2b. The cells were incubated
with mAbs for 20 min at 4°C, washed, resuspended in
PBS, and analyzed by flow cytometry using CellQuest
v.3.1 software. 
Mixed lymphocyte reactions (MLR) 
Peripheral blood mononuclear cells (PBMCs) isolat-
ed from EDTA-anticoagulated blood from healthy
donors by standard Ficoll/Isopaque density gradient cen-
trifugation were used as responding cells. Allogeneic
PBMCs (1.2×105/well) were added to irradiated (2500
cGy) DCs (1×102 to 1×104/well) and cultured in RPMI
1640 medium (Gibco) with 10% pooled human AB
serum for 6 days. One µCi/well of [3H]thymidine
(Amersham, Aylesbury, UK) was added for the final 18
h of culture, then the cells were harvested on a fiberglass
filter and isotope uptake was determined in a β scintilla-
tion counter (Beckman, Fullerton, CA). The results are
expressed as mean counts per minute (cpm) of triplicates.
Chemotaxis
The chemotactic assay was performed on Costar
Transwell 24-well plates with a 5-µm pore-size filter
(Costar Corning, Cambridge, MA). RPMI1640 medium
supplemented with 0.5% bovine serum albumin alone or
with macrophage inflammatory protein (MIP) 1α or
3β(CytoLab, both at 100 ng/ml) in a final volume of 650
µl was added to the lower chamber. The cells
(1×105/100 µl) were placed in the upper chamber. As
a control, 2×104 cells (i.e. 20%) were put into the lower
chamber. After 2 h the cells in the lower chamber of the
Transwell were harvested and their number determined
by flow cytometry. The cells were gated according to
their FSC/SSC parameters and counted during a 20-sec
acquisition time at a high flow rate. Data are expressed
as the percentage of migrating cells according to formu-
la: % of migrating cells = number of cells in the test well
×20%/number of cells in the control well.
Determination of phagocytosis and O2
– production
DCs (1×105/100 µl) were thoroughly rinsed with
RPMI 1640 medium without antibiotics and incubated
for 30 min at 37°C in medium containing 10 µM (final
concentration) of hydroethidine (HE, Sigma). Then
opsonized FITC-labeled S. aureus, prepared as previ-
ously described (Wêglarczyk et al. 2004), was added at
a bacteria-to-cell ratio of 20:1 and the cells were incu-
bated for a further 30 min at 37°C. Finally, 200 µl of
complete medium was added and the samples were ana-
lyzed by flow cytometry.
Statistical analysis 
The non-parametric Mann-Whitney test was per-
formed using GraphPad InStat version 2.0 software.
p values <0.05 were considered significant.
RESULTS
Expansion of CD34+ hematopoietic progenitor cells 
and generation of DCs
DCs were generated in two-step cultures. In the first
step, isolated CD34+ cells were grown in FST medium
for 7 days to expand hematopoietic progenitors. This
represented the initial inoculum of cells, indicated here-
after as day 0 of culture, that were grown in different
media. In the second step, the cells were transferred to
FST, FST3, and FST713 media. Every week the cells
were harvested and counted. The mean increase in total
cell number during the first week of culture in FST
medium was on average 12.6-fold. During the next 21
days the proliferation of cells was different in the FST,
FST3, and FST713 media (Fig. 1). The mean fold
increase in the total number of cells cultured in FST3
medium was 289, while in FST and FST713 only 42- and
6-fold, respectively. From the beginning of CD34+ cell
culture, i.e. during 28 days, the mean increase in the
total number of cells cultured in FST was 127-, in FST3
medium 1043-, and in FST713 medium 71-fold.
Surface markers expression
Immunophenotypic analysis carried out on day 21
revealed different expressions of surface markers on the
cells grown in the media used (Fig. 2). Almost all cells
were CD33+ (not shown), indicating their myeloid ori-
gin. FST713-iDCs showed a significantly decreased pro-
portion of CD14+ cells and enhanced levels of CD1a+,
CD40+, CD80+, CD83+, and HLA-DR+ cells compared70  B. Mytar et al.: Effect of IL-7 and IL-13 on DC generation
with FST-iDCs and FST3-iDCs (except for CD40 and
HLA-DR in the latter). The level of CD86+ cells was
also increased, although not significantly. Compared
with FST-iDCs and FST713-iDCs, cells from FST3
medium showed lower expressions of CD1a, CD80, and
CD83 and an elevated proportion of CD14+ (Fig. 2A).
There were no differences in CD36, CD11c, MR, and
CD123 expression (not shown). Maturation did not sig-
nificantly alter the expression of surface determinants
on FST713-DCs, except for some elevation of CD40+
cells. FST-DCs showed some increase in the numbers of
CD40+ and CD86+ cells. In the case of FST3 medium,
increase in CD80+ and CD83+ and a decrease in CD14+
cells were observed (Fig. 2B). 
Stimulation of allogeneic MLR
The allo-MLR stimulatory capacity of DCs expand-
ed and matured in the different media was compared.
iDCs generated in FST and FST3 medium were poor
stimulators (Fig. 3). In contrast, FST713-iDCs exhibited
significantly enhanced stimulatory capacity. Following
maturation for a further 2–3 days, enhanced allostimu-
latory capacity of cells cultured in all the media was
observed, but FST713-mDCs were still the most potent
stimulators. It was concluded that the use of FST713
medium was superior for generating mDCs with
increased allostimulatory capacity. 
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Fig. 1. Expansion of cord blood CD34+ progenitor cells. The cells
were grown in FST medium for 7 days culture (indicated as day 0),
then plated at 1×105/ml in FST, FST3, and FST713 media and cul-
tured for a further 21 days. Every week the cells were harvested,
counted, and split for further culture. The fold increase from the
beginning of CD34+ cell cultures is indicated. On average, during
the first 7 days cell yield was increased 12.6 fold. The highest total
number of cells was obtained in cultures with FST3 medium. Mean
± SEM of results obtained in five different experiments is shown.
Fig. 2. The expression of surface determinants on iDCs (A) and
mDCs (B). Cells were cultured in FST medium for 7 days and then
cultured in different media for a further 21 days. Mean ± SEM of
results obtained in seven different experiments is shown.
*Significantly different (p<0.05) from FST medium. 
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Fig. 3. The ability of DCs cultured in different media and added in
various amounts to stimulate allo-MLR. Cells were cultured as
described in Fig. 2. Data are expressed as [3H]Thymidine incorpo-
ration (cpm). Mean ± SEM of results obtained in seven different
experiments is shown.
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Chemotactic activity and chemokine receptors
The spontaneous migration of cells from all the
media was negligible (Fig. 4). The chemotaxis of FST3-
-iDCs and FST713-iDCs to MIP1α was comparable and
significantly increased in comparison with FST-iDCs.
Low chemotactic activity to MIP3β of the iDCs gener-
ated in all the media was observed. Maturation caused
a significant decrease in the chemotaxis of FST3-mDCs
and FST713-mDCs to MIP1α, while the migratory activ-
ity of FST-mDCs was similar to that of iDCs. The
chemotaxis of all the mDCs to MIP3β was significantly
increased, in particular that of FST713-mDCs. 
The expression of CCR1 by iDCs was seen only on
FST3-iDCs (Fig. 5); CCR5 expression was absent.
Surprisingly, FST713-iDCs exhibited a decreased num-
ber of CCR7+ (MIP3β receptor) cells compared with
the others. Maturation diminished the expression of
CCR1 on FST-DCs to the same low level observed on
FST- and FST713-mDCs. The proportion of CCR5+
DCs rose with maturation, although it was still below
10%. The expression of CCR7 on iDCs and mDCs from
FST medium was similar, in contrast to FST3-mDCs
and especially to FST713-mDCs, which was significant-
ly enhanced. Hence there was no clear relationship of
CCR1 and CCR5 expression and chemotaxis to MIP1α,
but there was some association between enhanced
expression of CCR7 on FST713-mDCs and their migra-
tion to MIP3β.
Phagocytic activity and O2
– production 
Engulfment of opsonized FITC-labeled S. aureus by
FST713-iDCs was significantly lower than that of the
iDCs from FST and FST3 media (Fig. 6). Also, the per-
centage of cells producing O2
–, as shown by their ability
to oxidase HE, was lowest in FST713-iDCs. Maturation
of cells from all media was associated with decreased
phagocytic activity. The FST- and FST3-mDCs, but not
FST713-mDCs, also showed a reduction in the propor-
tion of O2
–-producing cells.
DISCUSSION
To our knowledge, only limited data concerning the
effect of IL-7 and IL-13 cytokines on the generation and
activity of CD34+-derived DCs are available. The aim of
the present study was to evaluate the effect of IL-7 and
IL-13 used together on immunophenotype and biologi-
cal activity of DCs generated from CD34+ hematopoiet-
ic progenitor cells by two-step cultures. In the first step,
CD34+ cells were grown in FST medium for 7 days and
then, in the second step, differentiated in FST3 or
FST713 media for the next 21 days. Then part of the
Fig. 4. Chemotaxis of iDCs and mDCs to MIP1α and MIP3β. The
cells were grown in different media as indicated in Fig. 2. Mean ±
SEM of results obtained in six different experiments is shown.
*Significantly increased (p<0.05) compared with FST medium.
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Fig. 5. The expression of chemokine receptors by iDCs and mDCs
cultured in different media. Mean ± SEM of results obtained in
six different experiments is shown. *Significantly different
(p<0.05) compared with FST medium.
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Fig. 6. Phagocytosis and O2
– production by iDCs and mDCs gener-
ated in different media. Percentages of cells that phagocytosed
S. aureus and produced O2
– is shown. Mean ± SEM of results
obtained in seven different experiments is shown. *Significantly
different (p<0.05) compared with FST and FST3 medium.
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cells was further matured/differentiated by culturing in
the presence of proinflammatory cytokines and PGE2.
There were significant differences in the abilities of the
tested media to induce the proliferation of CD34+ cells.
The best with regard to yield and time of exponential
growth was FST3 medium. In contrast, cells grown in
FST medium containing only early-acting cytokines and
in FST713 medium containing cytokines which induce
DC differentiation (Li et al. 2000; Morse et al. 1999)
showed significantly less proliferation. 
The present studies show that, compared with FST
and FST3 media, the cells cultured in FST713 medium
expressed higher proportions of CD1a+, CD40+,
CD83+, HLA-DR+, CD80+, and CD86+ and a lower
proportion of CD14+ cells. Similar data were obtained
when DCs generated from blood monocytes in the pres-
ence of GM-SCF and IL-4 were compared with those
cultured in GM-CSF and IL-7 (Li et al. 2000) or GM-
-CSF and IL-13 (Spisek et al. 2001). In these cases,
increased expressions of the CD40, CD80, and CD86
determinants were observed. Also, Morse et al. (Morse
et al. 1999) showed that DCs from IL-13-containing
media exhibited higher expressions of MHC class I and
II and CD86 than DCs generated in “classical” GM-
-CSF- and IL-4-containing medium. Our results demon-
strated that FST713-iDCs showed a higher level of
CD83 expression. Sato et al. (1999) also observed that
IL-13-induced expression of CD83 on GM-CSF+IL-4
generated monocyte-derived DCs. This is in contrast to
reports showing an absence of CD83 on monocyte-
-derived iDCs cultured in GM-CSF+IL-7 (Li et al.
2000) or GM-CSF+IL-13 (Spisek et al. 2001). In these
cases, the level of CD83 increased after maturation. The
discrepancies observed may arise from different sources
of cells used for differentiation and/or short-term cul-
tures for the generation of DCs in GM-CSF-containing
media. The phenotypic differences between cells grown
in FST vs. FST3 vs. FST713 medium were noted in the
absence of any maturation factors and were still
observed after maturation. At the same time, the
expression of CD33 (implicating a myeloid origin),
CD40, CD11c, and CD123 on cells from all media used
was similar, which in connection with the observed dif-
ferences in the expression of costimulatory molecules
suggested their association with the stage of maturation
rather than the existence of separate subsets.
An important feature of DCs is their capacity to
stimulate the proliferation of T lymphocytes in an allo-
geneic MLR. The role of IL-7 in stimulating T-cell
response is underscored by observations that IL-7 main-
tained T-cell proliferation (Sorg et al. 1998) and that
IL-7-transduced leukemic cells enhanced allo-T-cell
reactivity and generated cytotoxic T cells against autol-
ogous leukemic blasts (Bello-Fernandez et al. 2003). In
fact, FST713-iDCs showed a higher ability to stimulate
MLR than cells grown in the other media. DC matura-
tion enhanced somewhat this activity, but the cells from
FST713 medium were still superior. This may indicate
that they are already more mature DCs. These results
are in agreement with other data showing that a higher
expression of costimulatory molecules and HLA-DR,
which we also observed, is connected with more efficient
MLR stimulation (Ahn and Agrawal 2005).
Our results showed that the chemotaxis of FST3-
and FST713-iDCs to MIP1α was comparable and high-
er than that of FST-iDCs. As MIP1α is a chemoattrac-
tant for iDCs, decreased migration ability with matura-
tion was noted, which is compatible with other studies
(Lin et al. 1998). Chemotaxis to MIP3β, a feature of
mDCs, of the FST- and FST713-iDCs was higher than
that of FST3-iDCs. This may indicate the presence of
more mature cells grown in these media. As expected,
maturation enhanced migration to MIP3β of the DCs
from all media. The highest number of migrating cells in
FST713-mDCs also indicates that they are more mature.
It appears that IL-3 and a combination of IL-7 and
IL-13 regulate the process of generation of DCs as
shown by their different chemotactic activity. In light of
the chemotactic properties, the pattern of expression of
some chemokine receptors was rather unexpected. iDCs
from FST3 and FST713 medium, which showed compa-
rable chemotaxis to MIP1α, expressed quite different
numbers of CCR1+ and a lack of CCR5+ cells. In con-
trast, cells from FST and FST3 medium showed no
expression of CCR1 and CCR5, but different migratory
properties. The lack of correlation between the level of
chemokine receptors and chemotactic response of
monocyte-derived and peripheral blood-derived DCs
has already been reported. Luft et al. (Luft et al. 2002)
showed that monocyte-derived DCs become migratory
or proinflammatory (nonmigratory) in the presence or
absence of PGE2, respectively, though both types of
DCs showed similar expressions of chemokine receptors
(CCR7 and CXCR4). Plasmacytoid and myeloid DCs
isolated from human blood also differ in their migrato-
ry response to inflammatory chemokines, but have sim-
ilar chemokine receptor expressions (Penna et al. 2001).
Discrepancies between chemotactic ability and
chemokine receptor levels may also suggest that other
receptors, such as adenosine receptors or CD44
(Avigdor et al. 2004; Parlato et al. 2001; Schnurr et al
2004), or a different signaling pathway may be involved.
However, there was an association of CCR5 expression
on mDCs and migration to MIP1α and CCR7 expres-
sion on FST713-mDCs and their chemotaxis to MIP3β. 
In contrast to professional phagocytes, which ingest
pathogens to kill and clear them from the tissues,
phagocytosis by DCs is connected with the processing of
antigens and their presentation (Nagl et al. 2002). DCs
show little phagocytic activity, which differs between
their subsets and the level of maturation. In contrast to
plasmacytoid DCs, myeloid DCs are phagocytic (Di
Nicola et al. 1999). Our results indicated that FST713-
-iDCs exhibited less phagocytic and O2
–-producing
capacities than DCs from other media, suggesting their
more mature phenotype. The poor O2
– production
observed here is in agreement with data of Nagl et al.
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indicated that suppression of O2
– generation occurs dur-
ing the differentiation of monocytes to DCs. Reactive
oxygen intermediates may also be involved in the signal-
ing pathways responsible for the expression of genes
and, consequently, phenotypic and functional changes.
The poor response to S. aureus may indicate that it is
connected rather with a signaling than a killing mecha-
nisms. In fact, O2
– and hydrogen peroxide induce matu-
ration of DCs, as shown by the increased expressions of
CD40, CD80, CD86, CD83, and HLA-DR molecules
and more efficient stimulation of T-cell proliferation
(Kantengwa et al. 2003; Rutault et al. 1999). 
In summary, cells grown in FST, FST3, and FST713
media differ in phenotype and some biological activities.
DCs cultured in FST713 are characterized by higher
expressions of maturation markers (CD1a, CD83), cos-
timulatory molecules (CD80, CD86), and HLA-DR,
higher allostimulatory activity and response to
MIP3β following maturation, and poor phagocytosis. It
is concluded that FST713 medium allows the generation
of a limited number of more mature DCs, while FST3
medium leads to the production of iDCs in high num-
bers. Hence the use of FST713 medium may be consid-
ered for the generation of mDCs for potential use in
cancer immunotherapy. 
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